Friday, November 21, 2025
HomeNews

News

Avidity Biosciences Announces Phase 1/2 EXPLORE44 Trial of AOC 1044 for Duchenne Muscular Dystrophy Mutations

Avidity Biosciences, Inc., a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates announced the Phase 1/2 EXPLORE44™...

WuXi Biologics and Toregem BioPharma Sign MOU for Development of Anti-USAG-1 Antibody

WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organization (CRDMO), and Toregem BioPharma, a biotech startup company from Kyoto University, announced that...

Hyundai Motor Group Announces Future Roadmap for Software Defined Vehicles

Hyundai Motor Group (the Group) announced a new global strategy to transform all vehicles to Software Defined Vehicles (SDVs) by 2025. The industry-leading initiative,...

Fluora Mini Lights Up Fall, Launching on Indiegogo on Oct. 11

color+light, lighting designers of multi-sensory experiences, announces the launch of the Fluora Mini on Indiegogo on Oct. 11. The smaller version of its best-selling...

Logic Expands Snowflake Partnership Internationally to Extend Data and Analytics to More Retailers

Logic, the world’s largest consultancy focused exclusively on the retail sector, announced that it has expanded its partnership with Snowflake, the Data Cloud company,...
0FansLike
0FollowersFollow
spot_img

Hot Topics